Sign in

KatrinaRogers.bsky.social

@krogersconsulting.com
230 followers 232 following 328 posts

The world needs your big idea! I help guide underrepresented founders and investors.

PostsRepliesMedia
KatrinaRogers.bsky.social @krogersconsulting.com · 09/10/2026
A stalled pilot is not always a sales problem. It may be a workflow problem. An evidence problem. A reimbursement problem. A procurement problem. Or a sign that the company is pursuing the wrong customer, use case, or business model.
100
KatrinaRogers.bsky.social @krogersconsulting.com · 02/10/2026
One for my fellow radiochemistry nerds. Nucleonica is what happens when the Chart of the Nuclides meets a deep, searchable toolbox. Half-lives, decay chains, spectra, dosimetry, shielding, and more. A quick isotope check can become a very productive nuclear data rabbit hole. nucleonica.com
000
KatrinaRogers.bsky.social @krogersconsulting.com · 25/09/2026
“Patent pending” does not tell an investor whether the company controls its IP, protects its lead product, has a clear road to market, or will retain protection long enough to create value. My latest Deal Screening Mastery article asks four better questions. thinkingkat.substack.com/p/deal-scree...
thinkingkat.substack.com
Deal Screening Mastery (Part 9 of 12): Beyond Patent Pending
Four questions investors should ask before treating life science IP as a defensible asset
000
KatrinaRogers.bsky.social @krogersconsulting.com · 19/09/2026
Former Carta expert Peter Walker leaves us with this thought: A SAFE valuation cap is not always a measure of traction. At pre-seed, two companies can raise the same amount and receive very different caps. The difference often comes down to investor confidence in the team.
100
KatrinaRogers.bsky.social @krogersconsulting.com · 11/09/2026
If you're building or investing in medtech, ask one simple question: What happens when a device fails in the field? The answer tells you more than most pitch decks. thinkingkat.substack.com/p/plan-for-f...
thinkingkat.substack.com
Plan for Field Service Before Day One
Why your Go-To-Market plan must address “who fixes it, how fast, and what happens when it breaks”
001
KatrinaRogers.bsky.social @krogersconsulting.com · 04/09/2026
FDA’s draft guidance on AI to support regulatory decision-making for drugs and biologics is a significant step toward defining what credible AI use should look like.
110
KatrinaRogers.bsky.social @krogersconsulting.com · 28/08/2026
FDA’s April 2026 warning letter to Purolea Cosmetics Lab is an important reality check on the use of AI in regulated operations.
210
KatrinaRogers.bsky.social @krogersconsulting.com · 22/08/2026
A commercialization plan doesn't exist in a vacuum. Payer concentration, GPO contracts, VAC reviews, provider fragmentation, and reimbursement pathways all shape what a company can realistically achieve.
110
KatrinaRogers.bsky.social @krogersconsulting.com · 14/08/2026
Life science founders: if you're fundraising, learn how healthcare investment bankers think. Their work goes far beyond M&A. They advise on capital raises, licensing, partnerships, strategic alternatives, and exits while helping investors understand the value behind the science.
110
KatrinaRogers.bsky.social @krogersconsulting.com · 07/08/2026
Hot take: “Not venture backable” is often code for “great business, wrong instrument.” I’ve written a new piece on alternate capital strategies for life science founders, options instead of forcing everything through a unicorn lens.
120
KatrinaRogers.bsky.social @krogersconsulting.com · 31/07/2026
Engagement metrics ≠ evidence. Revenue ≠ repeatable. New essay on why ""impressive"" and ""investable"" are not the same thing in healthcare deals: open.substack.com/pub/thinking...
open.substack.com
Deal Screening Mastery (Part 7 of 12): Proof, Not Motion
Telling Real Evidence from Mere Activity in Healthcare and Biotech Deals
020
KatrinaRogers.bsky.social @krogersconsulting.com · 24/07/2026
BLPN member Tim Mikhelashvili is hosting the 5th Annual Medical Innovation Olympics in NYC. Past Gold Medalist & fellow BLPN member David Mead is featured. If you're an early-stage health founder, check it out. The discount is on the homepage now. #MIO2026 medicalinnovationolympics.com
medicalinnovationolympics.com
Medical Innovation Olympics
5th Annual Competition for Healthcare Champions Rockefeller Center, New York Trials: June 12, September 18 Finals: October 16
010
KatrinaRogers.bsky.social @krogersconsulting.com · 17/07/2026
One of the reasons I follow Deb Haas is for her relentlessly practical AI advice. She reminds us that you’re not “bad at AI.” You were just handed a complex tool with zero instructions and told to swim.
100
KatrinaRogers.bsky.social @krogersconsulting.com · 10/07/2026
You don’t need a commercial team to have a commercial strategy. In my latest piece, I outline what “good enough” looks like at Pre-Seed, Phase 1, and Phase 2: patient journeys, a lean TPP, basic HEOR thinking, and clear partnering guardrails.
100
KatrinaRogers.bsky.social @krogersconsulting.com · 26/06/2026
505(b)(2) isn’t a loophole—it’s a strategy. For founders working on reformulations, combos, or new delivery of known drugs, this pathway can shrink timelines and de-risk development—if you understand the rules of the game. Too many decks throw “505(b)(2)” on a slide without a real plan behind it.
100
KatrinaRogers.bsky.social @krogersconsulting.com · 19/06/2026
Many decks talk about “reg risk” and “reimbursement” in a single bullet. This piece goes deeper: * How to test “What do regulators think you are?” * Why coding, coverage, and payment must be separate conversations * How policy (like orphan incentives or DME categories) can turn path risk into upside
100
KatrinaRogers.bsky.social @krogersconsulting.com · 12/06/2026
Audrey Greenberg's post is her personal take on Wharton professor Tiantain Yang's research about how trust underpins success for women in business. Worth a read. www.linkedin.com/posts/audrey...
linkedin.com
I grew up surrounded by strong women. My mother, grandmother, and great-grandmother were builders, entrepreneurs, mothers, wives. Women who carried families, created opportunity, solved problems, and…...
I grew up surrounded by strong women. My mother, grandmother, and great-grandmother were builders, entrepreneurs, mothers, wives. Women who carried families, created opportunity, solved problems, and ...
010
KatrinaRogers.bsky.social @krogersconsulting.com · 05/06/2026
Your unique value proposition isn't ""I'm good at my job."" Everyone in this field is good at their job. It's the specific combination of technical strengths, transferable skills, and differentiators that makes you the right person for a particular problem.
100
KatrinaRogers.bsky.social @krogersconsulting.com · 29/05/2026
Geneticist Dr. Mary-Claire King's work reminds us that some of the most powerful scientific ideas start from a deceptively simple premise.
100
KatrinaRogers.bsky.social @krogersconsulting.com · 22/05/2026
If your “Why now?” story collapses the moment someone asks about codes, waivers, or unit economics…it wasn’t a “Why now?” story. My latest article offers a four-lever framework to pressure-test timing in early healthcare and life sciences deals. thinkingkat.substack.com/publish/post...
thinkingkat.substack.com
Deal Screening Mastery (Part 5 of 12): "Why Now?" Is an Investment Question, Not a Marketing Slide
Learn How to Assess the Difference
000
KatrinaRogers.bsky.social @krogersconsulting.com · 15/05/2026
My Thought Leader Blythe Karow is once again contributing to Med Tech startup traction with a series of interviews with former CMS Chief Medical Officer Dr. Lee Fleisher. substack.com/home/post/p-...
substack.com
Is CMS Killing Breakthrough MedTech? A View from the Other Side
This article is part one of a three-part interview series with Dr. Lee Fleisher, former Chief Medical Officer of CMS, on what the breakthrough device coverage problem looks like from CMS's point of vi...
000
KatrinaRogers.bsky.social @krogersconsulting.com · 08/05/2026
VERVE 101 is often framed as a cool gene editing story; I see it as a stress test of our cholesterol model. If a single base edit in PCSK9 can durably lower LDL in primates and now early human trials, that’s a potent confirmation of the LDL receptor axis we’ve been building toward since the 1970s.
100
KatrinaRogers.bsky.social @krogersconsulting.com · 01/05/2026
MECHANISMS is one of the clearest explanations I have seen of why medical neurotech gets stuck between lab, clinic, and market—and what it would take to fix the system. www.linkedin.com/posts/sharen...
linkedin.com
Mechanisms in Medical Neurotech: A Systems Account | Sharena Rice, PhD posted on the topic | LinkedIn
What the Mech is going on? This came alive in a NASA Inventor's Notebook. For years, I was carrying observations I could not yet name, patterns I kept seeing across training, quality, connections, ca...
020
KatrinaRogers.bsky.social @krogersconsulting.com · 24/04/2026
In my latest Deal Screening Mastery article, I introduce Founder Problem Fit (FPF) as a practical way to answer: “Why is this team uniquely qualified to tackle this specific problem, at this moment, with these execution risks?” thinkingkat.substack.com/publish/post...
thinkingkat.substack.com
Deal Screening Mastery (Part 4 of 12): Founder-Problem Fit
Moving Beyond the “Great Team vs Great Idea” Trap
020
KatrinaRogers.bsky.social @krogersconsulting.com · 17/04/2026
Most founders don’t think seriously about risk until something goes sideways. Investors do. If you’re building in life sciences, your broker shouldn’t just be a policy salesperson—they should be a strategic partner helping you protect value, manage burn, and show you run a disciplined company.
250
KatrinaRogers.bsky.social @krogersconsulting.com · 13/04/2026
I’ve been writing a lot about AI in healthcare lately, and a new report from Intelligence Ventures just dropped that’s worth your time: The State of AI Healthcare 2026. It’s a real look at what’s actually getting built at pre-seed and seed. report.intelligencevc.com
report.intelligencevc.com
State of AI Healthcare 2026 | Intelligence Ventures
The most comprehensive view of the earliest-stage AI healthcare pipeline ever published. 621+ startups, 670 pitch decks, 9,942 pages analyzed.
000
KatrinaRogers.bsky.social @krogersconsulting.com · 06/04/2026
If you've ever thought "I want to invest in startups but I don't even know where to start"—this one's for you. I'm a Portfolia investor, and here's why that decision made sense for me as a woman building in life sciences. info.portfolia.com/women-in-wea...
info.portfolia.com
Women In Wealth Webinar Video Replay
Women control $25T in wealth — yet most sits uninvested. Watch the replay to learn how to put yours to work in venture capital alongside 2,000+ Portfolia members.
010
KatrinaRogers.bsky.social @krogersconsulting.com · 27/03/2026
Founders building in women's health — this one's for you. NFX's Women's Health 2.0 FAST funding window is open now through April 9th. Every applicant gets feedback. No ghosting. No idea is too early. fast.nfx.com/womens-healt...
fast.nfx.com
Women’s Health 2.0 FAST
$150K Uncapped SAFE or $1M-$3M SAFE for 15% - 25%. Investing in founders revolutionizing human longevity. No idea is too early. Apply by April 9th.
000
KatrinaRogers.bsky.social @krogersconsulting.com · 20/03/2026
Early stage founders and new fund managers are staring at the same problem from opposite sides of the table: what actually counts as a “great idea”? thinkingkat.substack.com/publish/post...
thinkingkat.substack.com
Deal Screening Mastery (Part 3 of 12): Fund Fit, Moats, and Milestones
A Qual‑and‑Quant Playbook for Picking Better Deals
132
KatrinaRogers.bsky.social @krogersconsulting.com · 13/03/2026
Women’s health founders and funders: if policy is not part of your strategy, you’re leaving impact and enterprise value on the table. Do you want a high-impact way to contribute? The photo shows my local women’s health advocates! womenshealthadvocates.org
Photo of four women, Stacia Rasmussen, Katrina Rogers, Erin Heuter, and Michaele Armstrong (left to right)
012
KatrinaRogers.bsky.social @krogersconsulting.com · 06/03/2026
The healthcare innovation confidence gap is real: what vendors promise doesn’t always survive real-world deployment. I break down the warning signs and share the three-question framework founders need to bridge this gap—before capital gets burned. thinkingkat.substack.com/publish/post...
thinkingkat.substack.com
The Healthcare Innovation Confidence Gap
Why Hype Outpaces Reality—And How to Close the Gap
010
KatrinaRogers.bsky.social @krogersconsulting.com · 27/02/2026
Your insurance broker should be a strategic partner — not just a form-filler. Join me for a practical workshop on using smart risk management to protect valuation, manage burn, and signal investor-ready governance. Mar 10 | 9–10am PT 🔗 www.eventbrite.com/e/smart-risk... #LifeScience #Biotech
040
KatrinaRogers.bsky.social @krogersconsulting.com · 20/02/2026
#Investors, how do you evaluate a #Startup Team? If you are not using a simple, scorable rubric you can defend in LP #diligence, consider the alternative in my #ThinkingKat newsletter this week. open.substack.com/pub/thinking...
open.substack.com
Deal Screening Mastery (Part 2 of 12): Stop Winging It on Team Quality
A Practical Framework for Spotting “Great Teams” in Life Sciences
020
KatrinaRogers.bsky.social @krogersconsulting.com · 13/02/2026
Stress‑test life sciences deal terms in seconds. Ambrosia’s calculator gives data‑driven benchmarks for upfronts, milestones, and royalties for the two most active therapeutic areas in biopharma licensing. www.linkedin.com/feed/update/...
linkedin.com
Dealmaking deserves better tools, not precedent valuations | Issa K. posted on the topic | LinkedIn
We trust data to pick which molecules to develop, then price the deals on precedent and gut feeling. Same asset. Same phase. Same indication. Three different banks, three different valuations. Tha...
000
KatrinaRogers.bsky.social @krogersconsulting.com · 06/02/2026
AI isn’t failing because the models are weak; it’s failing because we keep bolting them onto brittle systems, and that integration debt is where life science value quietly leaks away. I share the details in this week's #ThinkingKat newsletter. open.substack.com/pub/thinking...
open.substack.com
When AI Becomes Drag, Not Lift
The Cost of Broken Integration, Bad Data, and Failed Change
010
KatrinaRogers.bsky.social @krogersconsulting.com · 30/01/2026
What happens when a health technology platform is acquired by a new owner whose top KPI is profit? Read this serialized story and find out! www.linkedin.com/pulse/hostag...
linkedin.com
Hostage
Chapter One On the video call, Lisa Marchetti looked like she hadn't slept in days. Sarah had known Lisa for eight years—she'd been the one who sold Caritas the original Stratix contract, back when it...
000
KatrinaRogers.bsky.social @krogersconsulting.com · 23/01/2026
This week, the #ThinkingKat (that's me!) shares the first in a series about mastering your deal screening process. open.substack.com/pub/thinking...
open.substack.com
Deal Screening Mastery (Part 1 of 12)
Why Commercialization Plans Reveal Founder DNA
000
KatrinaRogers.bsky.social @krogersconsulting.com · 16/01/2026
If you believe that AI requires thoughtful people to step forward and engage in the social and ethical conversation, you should read this report. Thanks, NAACP and Sanofi, for starting the conversation. naacp.org/resources/bu...
naacp.org
Building a Healthier Future: Designing for AI Health Equity
010
KatrinaRogers.bsky.social @krogersconsulting.com · 11/01/2026
Hey, #Caturday cat guardians, I just finished this fun book on Catifying your home. Thought all the cat daddies and mommies would enjoy it, too. share.libbyapp.com/title/1578877
share.libbyapp.com
Catification
A New York Times bestseller! The star of Animal Planet’s hit television series My Cat from Hell, Jackson Galaxy, shows cat owners everywhere how to make their homes both cat-friendly and chic. Cat own...
020
KatrinaRogers.bsky.social @krogersconsulting.com · 10/01/2026
This week on #ThinkingKat, I continue my time-honored tradition of sharing a reading list for innovators. Enjoy! open.substack.com/pub/thinking...
open.substack.com
Your 2026 Nightstand
A Reading List for Better Bets
010
KatrinaRogers.bsky.social @krogersconsulting.com · 02/01/2026
Is something missing in your company or product's message? Is the name part of the problem? If so, I highly recommend you check out Arielle Jackson's article on naming (or re-naming) a brand, company, or product. www.linkedin.com/posts/hbarna...
linkedin.com
Naming (or re-naming) a company is consistently one of the most difficult challenges Arielle Jackson helps our founders with, and it's so powerful when done with intention. Today on The Review, sh...
Naming (or re-naming) a company is consistently one of the most difficult challenges Arielle Jackson helps our founders with, and it's so powerful when done with intention. Today on The Review, she de...
020
KatrinaRogers.bsky.social @krogersconsulting.com · 26/12/2025
Haley Bay Barna, partner at First Round Capital, shared an article by her colleague Arielle Jackson with a structured process for naming (or re-naming) a company. I highly recommend it as a guide! www.linkedin.com/feed/update/...
linkedin.com
Naming (or re-naming) a company is consistently one of the most difficult challenges Arielle Jackson helps our founders with, and it's so powerful when done with intention. Today on The Review, sh...
Naming (or re-naming) a company is consistently one of the most difficult challenges Arielle Jackson helps our founders with, and it's so powerful when done with intention. Today on The Review, she de...
000
KatrinaRogers.bsky.social @krogersconsulting.com · 19/12/2025
In this week’s ThinkingKat newsletter, I share what's coming in 2026, and invite you to join the Community! open.substack.com/pub/thinking...
open.substack.com
Every Membership Matters
Thanks to your support, we continue delivering fresh perspectives and exclusive access to our growing network.
000
KatrinaRogers.bsky.social @krogersconsulting.com · 12/12/2025
In this week’s ThinkingKat newsletter, I share a new video that walks you through my favorite strategy framework and how to put it into practice, step by step. I’ve also included real-world tactics for winning buy-in and building momentum with your team. open.substack.com/pub/thinking...
open.substack.com
Catalyzing Success: The Journey from Plan to Progress
Real-World Strategies for Leading Change
010
KatrinaRogers.bsky.social @krogersconsulting.com · 06/12/2025
Shelby, gone too soon. Sharing her sweet face with the Cativerse on #Caturday.
2170
KatrinaRogers.bsky.social @krogersconsulting.com · 05/12/2025
This week on #ThinkingKat, find out how to overcome team resistance and make steady progress on your strategic plan. Want more of Katrina's insights? Subscribe to her #ThinkingKat newsletter! thinkingkat.substack.com open.substack.com/pub/thinking...
open.substack.com
Catalyzing Success - Part II
Overcoming Resistance and Building Momentum in Life Science Strategy Implementation
010
KatrinaRogers.bsky.social @krogersconsulting.com · 29/11/2025
This week on #ThinkingKat, feast on an array of dishes! Want more of Katrina's insights? Subscribe to her #ThinkingKat newsletter! thinkingkat.substack.com open.substack.com/pub/thinking...
open.substack.com
#ThinkingKat: November Monthly Roundup
We harvested a feast of insights this month!
010
KatrinaRogers.bsky.social @krogersconsulting.com · 21/11/2025
This week on #ThinkingKat, get started on your 2026 strategic plan using Katrina's framework. open.substack.com/pub/thinking...
open.substack.com
Catalyzing Success
How to Create and Put Your Life Science Strategy Into Action
000
KatrinaRogers.bsky.social @krogersconsulting.com · 14/11/2025
This week on #ThinkingKat, get Katrina's quick tips for a startup self-assessment process. Want more of Katrina's insights? Subscribe to her #ThinkingKat newsletter! thinkingkat.substack.com open.substack.com/pub/thinking...
open.substack.com
From Vision to Metrics
The Life Science Leader’s Guide to Staying on Track
010
KatrinaRogers.bsky.social @krogersconsulting.com · 07/11/2025
This week on #ThinkingKat, we hear from Thought Leader Ernesto Chanona on the why and what of life science business development. Want more of Katrina's Thought Leaders? Subscribe to her #ThinkingKat newsletter! thinkingkat.substack.com open.substack.com/pub/thinking...
open.substack.com
Thinking Kat Meets Thought Leader Ernesto Chanona
and we talk about how to build business development skills!
010